Top compounds associated with response to LMLN


Feature Type Standardized
Nominal ANOVA
mRNA BYL-719 CTRPv2 pan-cancer AAC -0.018 0.7
mRNA Axitinib GDSC1000 pan-cancer AAC 0.014 0.7
mRNA BRD9876 CTRPv2 pan-cancer AAC 0.015 0.7
mRNA Panobinostat CCLE pan-cancer AAC -0.017 0.7
mRNA Bexarotene CTRPv2 pan-cancer AAC 0.014 0.7
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.013 0.7
mRNA etoposide GDSC1000 pan-cancer AAC 0.014 0.7
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.013 0.7
mRNA GSK1059615 CTRPv2 pan-cancer AAC -0.018 0.7
mRNA 968 CTRPv2 pan-cancer AAC -0.028 0.7
Download CSV